Diego Dongiovanni

Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study

B. Castagneto, Silvia Zai, Diego Dongiovanni et al. · American Journal of Clinical Oncology · 2005 · 70 citations

Medicine, Oncology, Pharmacology +17

Predicting gefitinib responsiveness in lung cancer by fluorescence <i>in situ</i> hybridization/chromogenic <i>in situ</i> hybridization analysis of <i>EGFR</i> and <i>HER2</i> in biopsy and cytology specimens

Lorenzo Daniele, Luigia Macrì, Marina Schena et al. · Molecular Cancer Therapeutics · 2007 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +14

Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?

Diego Dongiovanni, Lorenzo Daniele, C. Barone et al. · Lung Cancer · 2008 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +7

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

Vincenzo Dongiovanni, L Buffoni, Alfredo Berruti et al. · Cancer Chemotherapy and Pharmacology · 2005 · 13 citations

Medicine, Oncology, Pharmacology +11

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

M Schena, C. Barone, Nadia Birocco et al. · Cancer Chemotherapy and Pharmacology · 2004 · 11 citations

Medicine, Oncology, Pharmacotherapy +17